Advertisement

Topics

First stereotactic radiotherapy system designed for breast cancer receives FDA clearance

19:00 EST 21 Dec 2017 | AAAS

(University of Maryland School of Medicine) The GammaPod ™ -- a first-of-its kind stereotactic radiotherapy system to treat early stage breast cancer -- has received 510(k) clearance from the US Food and Drug Administration (FDA), paving the way for the manufacturer to bring the system to market for the treatment of breast cancer patients.

Original Article: First stereotactic radiotherapy system designed for breast cancer receives FDA clearance

NEXT ARTICLE

More From BioPortfolio on "First stereotactic radiotherapy system designed for breast cancer receives FDA clearance"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...